PAS
RCEL icon

Point72 Asia (Singapore)’s Avita Medical RCEL Stock Holding History

Point72 Asia (Singapore)’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$56 – 1197
2025
Q1 		$56 Buy
+7
New +$65 ﹤0.01% 813

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Point72 Asia (Singapore)'s RCEL Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 7 shares — an estimated $56 sold.

Point72 Asia (Singapore) first reported a position in RCEL in Q1 2025 and held it in 1 quarter. The position peaked at $56 in Q1 2025. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 7 Avita Medical shares in Q2 2025, an estimated $56.
  • Point72 Asia (Singapore) first reported a position in Avita Medical in Q1 2025 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Avita Medical position peaked at $56 in Q1 2025.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.